AIPLA 2023 Spring Meeting

Arlington, VA. May 1, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments in response to the U.S. Copyright Office’s Notice of Proposed Rulemaking on adjustments to its fee schedule.

Arlington, VA. April 17, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments on the Enlarged Board of Appeal’s 11 March 2026 preliminary opinion in G 1/25, addressing whether patent descriptions must be adapted following claim amendments.

Arlington, VA — April 17, 2026 — The American Intellectual Property Law Association (AIPLA) filed an amicus curiae brief with the U.S. Court of Appeals for the Federal Circuit in Range of Motion Products, LLC v. Armaid Company Inc., No. 23-2427, supporting rehearing and rehearing en banc. AIPLA urges the Court to restore clarity to design patent law by (1) reaffirming that Gorham v. White (1871) provides the sole governing test for infringement and forecloses any separate “plainly dissimilar” threshold, and (2) confirming that claim construction may not be used to exclude any visual portions of the overall claimed design.

Arlington, VA. March 30, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments to the China National Intellectual Property Administration (CNIPA) regarding the Draft Measures for the Administration of Prioritized Examination of Patents.

Arlington, VA. March 27, 2026 – The American Intellectual Property Law Association (AIPLA) filed an amicus curiae brief with the Supreme Court in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., No. 24-889. AIPLA urges the Court to affirm the Federal Circuit’s application of the established Iqbal/Twombly pleading standard and inducement law in reviewing Hikma’s motion to dismiss Amarin’s claim that Hikma’s conduct, in combination with its “skinny label,” induced infringement of Amarin’s patented treatment methods.